NCT05995561 is a clinical trial of no intervention is planned. in Atrial Fibrillation, sponsored by University Hospital Heidelberg.

Who is sponsoring NCT05995561?

NCT05995561 is sponsored by University Hospital Heidelberg.

What drugs are being tested in NCT05995561?

Interventions in NCT05995561: no intervention is planned..

What condition does NCT05995561 study?

NCT05995561 studies Atrial Fibrillation.

Is NCT05995561 still recruiting?

NCT05995561 is currently completed. Last updated 9 May 2024.

Last reviewed 2024-05-09 · How we verify

NCT05995561

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HERA FIb Registry for Patients With Atrial Fibrillation

Completed Last updated 9 May 2024

What this trial tests

trial testing no intervention is planned. in Atrial Fibrillation in 12,297 participants. Completed in 1 April 2020.

Timeline

1 June 2009

Primary endpoint
1 April 2020

1 April 2020

Quick facts

Lead sponsor	University Hospital Heidelberg
Status	Completed
Study type	OBSERVATIONAL
Enrollment	12,297
Start date	1 June 2009
Primary completion	1 April 2020
Estimated completion	1 April 2020
Sites	1 location across Germany

Drugs / interventions tested

no intervention is planned.

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

University Hospital Heidelberg

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Design, Rationale and Initial Findings From HERA-FIB on 10 222 Patients With Atrial Fibrillation Presenting to an Emergency Department Over An 11-Year Period.
Salbach C, Yildirim M, Hund H, Biener M, et al · · 2024 · cited 7× · PMID 38639359 · DOI 10.1161/jaha.123.033396
Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry.
Yildirim M, Hund H, Mueller-Hennessen M, Katus HA, et al · · 2025 · cited 6× · PMID 39867851 · DOI 10.1016/j.ijcha.2025.101598
Outcomes and Disease Management in Patients With Atrial Fibrillation ≥80 Years: Data From a Consecutive 11-Year Real-World Registry.
Yildirim M, Milles BR, Hund H, Biener M, et al · · 2025 · cited 4× · PMID 39921512 · DOI 10.1161/jaha.124.036832
Improvement in risk prediction for patients with atrial fibrillation and intermediate-risk CHA2DS2-VASc score utilizing highly sensitive cardiac troponin T.
Salbach C, Yildirim M, Milles BR, Hund H, et al · · 2025 · cited 2× · PMID 40839563 · DOI 10.1371/journal.pone.0330164
Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry.
Yildirim M, Salbach C, Dürr J, Mueller-Hennessen M, et al · · 2026 · PMID 41984154 · DOI 10.1007/s00392-026-02912-8
Effect of non-invasive rhythm control on outcomes in patients with first diagnosed atrial fibrillation presenting to an emergency department.
Salbach C, Yildirim M, Hund H, Müller-Hennessen M, et al · · 2025 · PMID 40033211 · DOI 10.1186/s12873-025-01194-z
Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry.
Salbach C, Milles BR, Hund H, Biener M, et al · · 2024 · PMID 39312541 · DOI 10.1371/journal.pone.0310838

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other University Hospital Heidelberg trials

Trials by the same sponsor.

NCT07388147 — Exercise Therapy for Multiple Myeloma Patients · NA · not yet recruiting
NCT07348874 — Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany · not yet recruiting
NCT07181928 — Is Mentalization-based Therapy More Effective Than Treatment-as-usual for Adolescents With Dissocial Disorders? · NA · not yet recruiting
NCT06954623 — Partial Breast Re-irradiation for Breast Cancer · NA · recruiting
NCT06913010 — DV 100 as a Framework for the Hospital Incident Command System · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05995561 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Heidelberg
Last refreshed: 9 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05995561.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing